Promimic AB (publ) engages in the manufacturing, marketing, and sale of biomaterials for improved osseointegration in the orthopedic and dental implants markets in Sweden. It offers HAnano surface which combines several properties that are known to improve osseointegration into one unique surface modification; and nano-sized crystalline powder or suspension hydroxyapatite can be used in r and d, as an ingredient in bone substitutes or as a chromatography material. The company was incorporated in 2004 and is headquartered in Mölndal, Sweden.
Frequently asked questions
What sector does Promimic AB (PRO) operate in?
Promimic AB belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Promimic AB (PRO) current stock price?
As of the latest data, Promimic AB stock price is SEK 10.10, with a previous close of SEK 10.10.
What is Promimic AB (PRO) current market capitalization?
Promimic AB market cap is approximately 190.81 million.
What is Promimic AB (PRO) Earnings Per Share (EPS)?
The trailing EPS is -SEK 0.98.
What is Promimic AB (PRO) EBITDA?
Promimic AB EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -1.90 million.
Does Promimic AB (PRO) pay dividends?
No. Promimic AB does not pay a dividend.
What is Promimic AB (PRO) beta (volatility) score?
Promimic AB has a beta of -0.314, indicating lower volatility than the overall market.